These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation. Smith VB; Spina D Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135 [TBL] [Abstract][Full Text] [Related]
9. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor. Karish SB; Gagnon JM Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669 [TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease. Giembycz MA Proc Am Thorac Soc; 2005; 2(4):326-33; discussion 340-1. PubMed ID: 16267357 [TBL] [Abstract][Full Text] [Related]
11. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Salem EA; Kendirci M; Hellstrom WJ Curr Opin Investig Drugs; 2006 Jul; 7(7):661-9. PubMed ID: 16869121 [TBL] [Abstract][Full Text] [Related]
12. Bioactive triterpenoids from Vochysia pacifica interact with cyclic nucleotide phosphodiesterase isozyme PDE4. Weniger B; Lobstein A; Um BH; Vonthron-Sénéchau C; Anton R; Usuga NJ; Basaran H; Lugnier C Phytother Res; 2005 Jan; 19(1):75-7. PubMed ID: 15798995 [TBL] [Abstract][Full Text] [Related]
13. An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease. Giembycz MA Br J Clin Pharmacol; 2006 Aug; 62(2):138-52. PubMed ID: 16842388 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Dastidar SG; Rajagopal D; Ray A Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865 [TBL] [Abstract][Full Text] [Related]
16. Roflumilast for the treatment of chronic obstructive pulmonary disease. Antoniu SA Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716 [TBL] [Abstract][Full Text] [Related]
17. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases]. Xia XD; Dai YR; Xu ZJ Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829 [No Abstract] [Full Text] [Related]
18. [Inflammatory lung and systemic disease]. Med Monatsschr Pharm; 2005 Jul; 28(7):254-5. PubMed ID: 16038131 [No Abstract] [Full Text] [Related]